GWPH - Is GW Pharmaceuticals an Opportunity Before Earnings?
GW Pharmaceuticals (NASDAQ: GWPH), a U.K.-based company, is a biotech that has pioneered the medical cannabis field and is capitalizing on its first-mover advantage.
Founded in 1998, biotech veterans Dr. Geoffrey Guy and Dr. Brian Whittle worked closely with U.K. regulatory agencies in establishing necessary licenses and procedures to facilitate cannabinoid medical research. The first GW Pharmaceuticals clinical trials began in 1999.
By contrast, U.S. biotech companies still face multiple federal regulation hurdles in even primary medical cannabinoid research and clinical trials. Though many states have legalized cannabis, research and development remains limited until there is federal legalization.